Dr. Anil Kumar Bhandari, MD

Dr. Bhandari practices at PIH Health Physicians in Los Angeles, California.

Dr. Bhandari's NPI, 1669466439, was assigned on September 7, 2005. Dr. Bhandari graduated from All India Institute of Medical Sciences in 1976. Dr. Bhandari holds California license A39656.

Dr. Bhandari's primary practice is PIH Health Physicians, at 1245 W Wilshire Blvd, Los Angeles, CA 90017 in Los Angeles County. The practice phone is (213) 977-0419.

Dr. Bhandari's primary practice is PIH Health Physicians in Los Angeles, California. Dr. Bhandari is also affiliated with PIH Health Good Samaritan Hospital. The medical group on file is PIH Health Physicians. Dmand AI also links Dr. Bhandari to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhandari practices. Vendor and product names are available with a free account.

Clinical cardiac electrophysiology is Dr. Bhandari's primary specialty in the NPI Registry, under taxonomy code 207RC0001X. Dr. Bhandari is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Bhandari is licensed in California.

Dmand AI lists atrial fibrillation and flutter, cardiac arrhythmia, heart blockage, intermittent racing heartbeat (PSVT), sick sinus syndrome and ventricular tachycardia among the conditions Dr. Bhandari treats.

CMS data shows 1,883 Medicare services from Dr. Bhandari across 17 procedure codes in 2024, for 690 Medicare patients. Medicare paid $105,715 for them.

CMS counts 690 Medicare patients who saw Dr. Bhandari in 2024. The largest group is 75 to 84, with 300 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhandari's median patient age at 74, with 42% women.

In 2024, Dr. Bhandari wrote 2,195 Medicare Part D claims for 309 patients. 76% of them were for generic drugs. CMS names the drug for 1,961 of them, across 37 drugs with 11 or more claims each, at $618,160 in total drug cost. In 2023, CMS named 1,694 claims across 35 drugs.

Dr. Bhandari accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bhandari as offering telehealth.

Dmand AI links 5 papers to Dr. Bhandari, published from 2010 to 2015. Dr. Bhandari's most frequent co-authors are John F. Beshai, MD, Frank M. Bogun, MD and David Shefveland Cannom, MD.

Dmand AI links Dr. Bhandari to 1 clinical trial. Conditions studied include Atrial Fibrillation and Arrhythmias, Cardiac.

CMS Open Payments shows 265 general payments to Dr. Bhandari from 16 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 51% of the total. Janssen Pharmaceuticals, Inc paid the most, $95,329. It also lists 2 research payments totaling $3,300 in 2016.

Dr. Bhandari graduated from All India Institute of Medical Sciences in 1976.

Dr. Bhandari is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.